Andere talen Gentian Diagnostics

Aandelen

GENT

NO0010748866

Beurs gesloten - Oslo Bors Andere beurzen 16:45:00 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
39,4 ^NOK	+2,07%		-1,01%	-5,06%

30/04	Gentian Diagnostics ASA rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
30/04	Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Gentian Diagnostics : 30 April 2024 - Quarterly Presentation - Q1 2024	30/04
Gentian Diagnostics : 30 April 2024 - Quarterly Report - Q1 2024	30/04
Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors	29/04
Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO	29/04
Gentian Diagnostics: New acting CEO and Chairperson of the Board of Directors	29/04
Gentian Diagnostics : Scientists to Gentian’s R&D department	08/04
Gentian Diagnostics ASA Announces Resignation of Hilja Ibert as CEO, Effective on April 29, 2024	21/03
Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024	21/03
Gentian Diagnostics' CEO Resigns, Wins Recommendation to Succeed Chair	21/03
Gentian Diagnostics ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	09/02
Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors	18/12
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference	14/12
Gentian Diagnostics ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26-10-23
Gentian Diagnostics : Sales and Application Specialist - Nordic	10-10-23
Gentian Diagnostics ASA Expands Product Portfolio With Turbidimetric Retinol-Binding Protein Immunoassay	29-09-23
Gentian Diagnostics ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24-08-23
Gentian Diagnostics ASA (OB:GENT) acquired Getica Ab from Erling Sundrehagen for SEK 2.8 million.	03-07-23
Norway's Gentian Diagnostics Buys Sweden-based Getica in SEK3 Million Deal	15-06-23
Gentian Diagnostics ASA (OB:GENT) entered into an agreement to acquire Getica Ab from Erling Sundrehagen for SEK 3 million.	15-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Gentian Diagnostics

Aandelen

GENT

NO0010748866

Andere talen

Filters